A pan-cancer analysis of 33 tumor types reveals that the DNA-repair kinases TLK1 and TLK2 drive genomic instability and shape ...
Scientists Find a Shared Weakness That Could Crack Triple-Negative Breast Cancer’s Drug Resistance
New research shows that triple-negative breast cancer cells rely on shared DNA damage tolerance enzymes such as POLζ and CHK1 ...
Roche receives US FDA approval for Tecentriq-based adjuvant treatment of stage III dMMR colon cancer
Roche announced US FDA approval of Tecentriq and Tecentriq Hybreza in combination with fluoropyrimidine- and oxaliplatin-based chemotherapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results